ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	5/20	120/7206	1.49526643049e-05
ko05212	Pancreatic cancer	3/20	83/7206	0.00145830725498
ko04060	Cytokine-cytokine receptor interaction	4/20	191/7206	0.00166073119633
ko05200	Pathways in cancer	6/20	492/7206	0.0016680972608
ko04672	Intestinal immune network for IgA production	2/20	37/7206	0.00459869363023
ko05142	Chagas disease (American trypanosomiasis)	3/20	130/7206	0.00522511985387
ko04380	Osteoclast differentiation	3/20	134/7206	0.00568605440606
ko04933	AGE-RAGE signaling pathway in diabetic complications	3/20	135/7206	0.00580500687732
ko05166	HTLV-I infection	4/20	292/7206	0.00765205706082
ko05160	Hepatitis C	3/20	153/7206	0.00820731532833
ko04725	Cholinergic synapse	3/20	160/7206	0.00927873931685
ko04071	Sphingolipid signaling pathway	3/20	162/7206	0.0095993155007
ko05321	Inflammatory bowel disease (IBD)	2/20	56/7206	0.0103036194612
ko04068	FoxO signaling pathway	3/20	167/7206	0.0104291694394
ko04010	MAPK signaling pathway	4/20	321/7206	0.0106278601635
ko05213	Endometrial cancer	2/20	62/7206	0.0125268875025
ko05221	Acute myeloid leukemia	2/20	63/7206	0.0129161953644
ko04932	Non-alcoholic fatty liver disease (NAFLD)	3/20	182/7206	0.0131659372089
ko05168	Herpes simplex infection	3/20	182/7206	0.0131659372089
ko05223	Non-small cell lung cancer	2/20	66/7206	0.0141156959123
ko05152	Tuberculosis	3/20	187/7206	0.0141618238936
ko04072	Phospholipase D signaling pathway	3/20	197/7206	0.0162809006662
ko05214	Glioma	2/20	79/7206	0.0198438873908
ko05230	Central carbon metabolism in cancer	2/20	81/7206	0.0207990935108
ko05131	Shigellosis	2/20	82/7206	0.0212838686561
ko05220	Chronic myeloid leukemia	2/20	85/7206	0.0227665545374
ko05218	Melanoma	2/20	85/7206	0.0227665545374
ko05210	Colorectal cancer	2/20	86/7206	0.0232701461567
ko04924	Renin secretion	2/20	86/7206	0.0232701461567
ko05323	Rheumatoid arthritis	2/20	89/7206	0.0248086327667
ko05211	Renal cell carcinoma	2/20	96/7206	0.0285566737488
ko05100	Bacterial invasion of epithelial cells	2/20	99/7206	0.0302290875644
ko05146	Amoebiasis	2/20	99/7206	0.0302290875644
ko01521	EGFR tyrosine kinase inhibitor resistance	2/20	106/7206	0.0342805354253
ko04810	Regulation of actin cytoskeleton	3/20	264/7206	0.0349492718781
ko04012	ErbB signaling pathway	2/20	109/7206	0.0360791481599
ko05215	Prostate cancer	2/20	111/7206	0.0372984842055
ko05205	Proteoglycans in cancer	3/20	271/7206	0.0373511655587
ko04912	GnRH signaling pathway	2/20	122/7206	0.0442852650598
ko04750	Inflammatory mediator regulation of TRP channels	2/20	122/7206	0.0442852650598
ko04066	HIF-1 signaling pathway	2/20	123/7206	0.0449432880023
ko01522	Endocrine resistance	2/20	124/7206	0.0456050186367
ko05145	Toxoplasmosis	2/20	126/7206	0.0469395097387